Sphingolipid Biology of Cancer
$578,426ZIAFY2017DKNIH
National Institute Of Diabetes And Digestive And Kidney Diseases
Investigators
Linked publications & trials
Paper 28802842Paper 25831442Paper 25332431Paper 24667638Paper 22735358Paper 21642988Paper 21173151Paper 20404103Paper 20097939Paper 17400555Paper 16980623
Abstract
Shpingosine-1-phosphate (S1P) is a bioactive lipid mediator that interacts with a a family of G-protein coupled receptors. S1P signaling regulates several of the hallmarks of cancer including the induction of angiogenesis, resisting cell death, sustaining proliferative signaling, tumor-promoting inflammation and activating invasion and metastasis. Furthermore, S1P metabolism has been found to be disturbed in several types of tumors providing further support for a linkage between pleiotropic actions of S1P to oncogenesis. We are using novel S1P signaling reporter mice to identify S1P receptor signaling in live mice in response to tumor development, growth and metastasis.
View original record on NIH RePORTER →